Germany
· Delayed Price · Currency is EUR Redcare Pharmacy NV Statistics
Total Valuation
Redcare Pharmacy NV has a market cap or net worth of EUR 2.90 billion. The enterprise value is 2.97 billion.
| Market Cap | 2.90B |
| Enterprise Value | 2.97B |
Important Dates
The last earnings date was Tuesday, November 5, 2024.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Redcare Pharmacy NV has 20.34 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 20.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.18% |
| Owned by Institutions (%) | 31.96% |
| Float | 13.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 129.51 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 135.15, with an EV/FCF ratio of 132.32.
| EV / Earnings | -120.83 |
| EV / Sales | 1.33 |
| EV / EBITDA | 135.15 |
| EV / EBIT | n/a |
| EV / FCF | 132.32 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.46.
| Current Ratio | 2.12 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 11.18 |
| Debt / FCF | 10.87 |
| Interest Coverage | -1.65 |
Financial Efficiency
Return on equity (ROE) is -4.56% and return on invested capital (ROIC) is -1.10%.
| Return on Equity (ROE) | -4.56% |
| Return on Assets (ROA) | -0.86% |
| Return on Capital (ROIC) | -1.10% |
| Revenue Per Employee | 1.17M |
| Profits Per Employee | -12,928 |
| Employee Count | 2,074 |
| Asset Turnover | 2.11 |
| Inventory Turnover | 12.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.74% in the last 52 weeks. The beta is 1.03, so Redcare Pharmacy NV's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +17.74% |
| 50-Day Moving Average | 140.65 |
| 200-Day Moving Average | 132.43 |
| Relative Strength Index (RSI) | 44.02 |
| Average Volume (20 Days) | 62,510 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Redcare Pharmacy NV had revenue of EUR 2.23 billion and -24.56 million in losses.
| Revenue | 2.23B |
| Gross Profit | 516.65M |
| Operating Income | -14.53M |
| Pretax Income | -29.39M |
| Net Income | -24.56M |
| EBITDA | 15.53M |
| EBIT | -14.53M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 209.90 million in cash and 243.73 million in debt, giving a net cash position of -33.83 million or -1.66 per share.
| Cash & Cash Equivalents | 209.90M |
| Total Debt | 243.73M |
| Net Cash | -33.83M |
| Net Cash Per Share | -1.66 |
| Equity (Book Value) | 534.55M |
| Book Value Per Share | n/a |
| Working Capital | 272.15M |
Cash Flow
In the last 12 months, operating cash flow was 31.00 million and capital expenditures -8.57 million, giving a free cash flow of 22.43 million.
| Operating Cash Flow | 31.00M |
| Capital Expenditures | -8.57M |
| Free Cash Flow | 22.43M |
| FCF Per Share | 1.10 |
Margins
Gross margin is 23.20%, with operating and profit margins of -0.65% and -1.10%.
| Gross Margin | 23.20% |
| Operating Margin | -0.65% |
| Pretax Margin | -1.32% |
| Profit Margin | -1.10% |
| EBITDA Margin | 0.70% |
| EBIT Margin | -0.65% |
| FCF Margin | 1.01% |
Dividends & Yields
Redcare Pharmacy NV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 0.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |